SGMT
Price
$5.26
Change
-$0.68 (-11.45%)
Updated
Dec 18, 04:59 PM (EDT)
SLRN
Price
$3.27
Change
-$0.23 (-6.57%)
Updated
Dec 18, 04:59 PM (EDT)
Ad is loading...

SGMT vs SLRN

Header iconSGMT vs SLRN Comparison
Open Charts SGMT vs SLRNBanner chart's image
Sagimet Biosciences
Price$5.26
Change-$0.68 (-11.45%)
Volume$4.9K
CapitalizationN/A
ACELYRIN
Price$3.27
Change-$0.23 (-6.57%)
Volume$47.34K
CapitalizationN/A
SGMT vs SLRN Comparison Chart
Loading...
SGMT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SLRN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
SGMT vs. SLRN commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SGMT is a StrongBuy and SLRN is a Hold.

COMPARISON
Comparison
Dec 19, 2024
Stock price -- (SGMT: $5.94 vs. SLRN: $3.50)
Brand notoriety: SGMT and SLRN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: SGMT: 185% vs. SLRN: 109%
Market capitalization -- SGMT: $191.24M vs. SLRN: $351.14M
SGMT [@Biotechnology] is valued at $191.24M. SLRN’s [@Biotechnology] market capitalization is $351.14M. The market cap for tickers in the [@Biotechnology] industry ranges from $486.73B to $0. The average market capitalization across the [@Biotechnology] industry is $2.67B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

SGMT’s FA Score shows that 0 FA rating(s) are green whileSLRN’s FA Score has 1 green FA rating(s).

  • SGMT’s FA Score: 0 green, 5 red.
  • SLRN’s FA Score: 1 green, 4 red.
According to our system of comparison, SGMT is a better buy in the long-term than SLRN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SGMT’s TA Score shows that 7 TA indicator(s) are bullish while SLRN’s TA Score has 4 bullish TA indicator(s).

  • SGMT’s TA Score: 7 bullish, 2 bearish.
  • SLRN’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, SGMT is a better buy in the short-term than SLRN.

Price Growth

SGMT (@Biotechnology) experienced а +21.47% price change this week, while SLRN (@Biotechnology) price change was -13.79% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -6.67%. For the same industry, the average monthly price growth was -1.92%, and the average quarterly price growth was +0.65%.

Reported Earning Dates

SGMT is expected to report earnings on Nov 14, 2024.

SLRN is expected to report earnings on Nov 13, 2024.

Industries' Descriptions

@Biotechnology (-6.67% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SLRN($351M) has a higher market cap than SGMT($169M). SGMT YTD gains are higher at: 9.594 vs. SLRN (-53.083). SGMT has higher annual earnings (EBITDA): -45.73M vs. SLRN (-324.52M). SLRN has more cash in the bank: 562M vs. SGMT (152M). SGMT has less debt than SLRN: SGMT (116K) vs SLRN (6.56M). SGMT (0) and SLRN (0) have equivalent revenues.
SGMTSLRNSGMT / SLRN
Capitalization169M351M48%
EBITDA-45.73M-324.52M14%
Gain YTD9.594-53.083-18%
P/E RatioN/AN/A-
Revenue00-
Total Cash152M562M27%
Total Debt116K6.56M2%
TECHNICAL ANALYSIS
Technical Analysis
SGMTSLRN
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
70%
Bearish Trend 2 days ago
89%
MACD
ODDS (%)
Bullish Trend 2 days ago
90%
N/A
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
87%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
89%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
79%
Declines
ODDS (%)
Bearish Trend 6 days ago
90%
Bearish Trend 8 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
73%
Bullish Trend 2 days ago
89%
Aroon
ODDS (%)
Bullish Trend 2 days ago
77%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
SGMT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SLRN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PGOFX49.87N/A
N/A
Pioneer Select Mid Cap Growth A
MNBIX19.72N/A
N/A
Manning & Napier Pro-Blend Extnd Term I
FEOPX16.79N/A
N/A
Fidelity Enduring Opportunities
PIIJX13.89-0.03
-0.22%
Principal Diversified Intl J
ESMYX14.16-0.08
-0.56%
Invesco EQV Euro Small Company Y

SGMT and

Correlation & Price change

A.I.dvisor tells us that SGMT and CRSP have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SGMT and CRSP's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SGMT
1D Price
Change %
SGMT100%
+3.66%
CRSP - SGMT
32%
Poorly correlated
+0.88%
ALLO - SGMT
32%
Poorly correlated
+0.49%
TRDA - SGMT
31%
Poorly correlated
+2.44%
SLRN - SGMT
30%
Poorly correlated
+3.86%
PLRX - SGMT
30%
Poorly correlated
+4.74%
More

SLRN and

Correlation & Price change

A.I.dvisor indicates that over the last year, SLRN has been loosely correlated with FATE. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if SLRN jumps, then FATE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SLRN
1D Price
Change %
SLRN100%
+3.86%
FATE - SLRN
40%
Loosely correlated
-6.00%
ABCL - SLRN
39%
Loosely correlated
-2.45%
RCKT - SLRN
39%
Loosely correlated
+1.36%
IDYA - SLRN
39%
Loosely correlated
+1.07%
CMND - SLRN
38%
Loosely correlated
-3.05%
More